HEK/Commission for Evaluation of Pharmaceuticals: Methods, workflows, assessment procedures
02-19-2007 | 16:00 | Ludwig Boltzmann Institut für Health Technology Assessment
The HEK is a drug review body and acts as advisor. It makes reimbursement recommendations to the Austrian National Insurance.
The seminar is open to the public, due to the lack of space we ask you to register at email@example.com.
Location: Library of the LBI-HTA
Beginning: 4 p.m.
End: 6 p.m.